These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6180128)

  • 41. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
    Tanswell P; Heinzel G; Greischel A; Krause J
    J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Appearance and determination of interferon in the bile of rabbits].
    Bargigli V; Russi-Sorce M; Pacini A; Pessina GP; Bocci V
    Boll Soc Ital Biol Sper; 1977 May; 53(9):684-9. PubMed ID: 911516
    [No Abstract]   [Full Text] [Related]  

  • 43. Degradation of human 125I-interferon alpha by isolated perfused rabbit kidney and liver.
    Bocci V; Mogensen KE; Muscettola M; Pacini A; Paulesu L; Pessina GP; Skiftas S
    J Lab Clin Med; 1983 Jun; 101(6):857-63. PubMed ID: 6854125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
    J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of neuraminidase on the rabbit urinary interferon.
    Viti A; Bocci V; Russi M; Rita G
    Experientia; 1970 Apr; 26(4):363-4. PubMed ID: 5462174
    [No Abstract]   [Full Text] [Related]  

  • 46. Clearance of human interferon in rabbits induced to make rabbit interferon.
    Pyhala L; Cantell K
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):394-7. PubMed ID: 4834448
    [No Abstract]   [Full Text] [Related]  

  • 47. Interferon crosses blood-cerebrospinal fluid barrier in monkeys.
    Habif DV; Lipton R; Cantell K
    Proc Soc Exp Biol Med; 1975 May; 149(1):287-9. PubMed ID: 1144440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microsequence analysis of peptides and proteins. IV. Structural studies on human leukocyte interferons.
    Shively JE; Del Valle U; Blacher R; Hawke D; Levy WP; Rubinstein M; Stein S; McGregor C; Tarnowski J; Bartlett R; Lee D; Pestka S
    Anal Biochem; 1982 Nov; 126(2):318-26. PubMed ID: 6186155
    [No Abstract]   [Full Text] [Related]  

  • 49. Interferon: pharmacokinetics and toxicity.
    Scott GM
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of liver in the inactivation of interferon.
    Bocci V; Russi-Sorce M; Cirri G; Rita G
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):62-5. PubMed ID: 4176732
    [No Abstract]   [Full Text] [Related]  

  • 51. Which will be the most useful interferon?
    Bocci V
    Ric Clin Lab; 1981; 11(1):27-32. PubMed ID: 6164090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 53. The hepatic clearance of circulating native and asialo carcinoembronic antigen by the rat.
    Thomas P; Hems DA
    Biochem Biophys Res Commun; 1975 Dec; 67(3):1205-9. PubMed ID: 1201069
    [No Abstract]   [Full Text] [Related]  

  • 54. Induction of circulating interferon by synthetic anionic polymers of known composition.
    Merigan TC
    Nature; 1967 Apr; 214(5086):416-7. PubMed ID: 6032855
    [No Abstract]   [Full Text] [Related]  

  • 55. [The pharmacokinetics of interferons].
    Ogarkov VI; Lapina GF
    Antibiot Med Biotekhnol; 1986 Sep; 31(9):712-5. PubMed ID: 2430520
    [No Abstract]   [Full Text] [Related]  

  • 56. INTERFERON: A CELLULAR PRODUCT WHICH INHIBITS VIRUSES.
    PAUCKER K
    Clin Pediatr (Phila); 1964 Nov; 3():671-8. PubMed ID: 14218971
    [No Abstract]   [Full Text] [Related]  

  • 57. [INTERFERONS].
    POPESCU M
    Stud Cercet Inframicrobiol; 1963; 14():217-37. PubMed ID: 14044571
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of cross-species activity of mammalian interferons.
    Carter WA
    Pharmacol Ther; 1979; 7(2):245-52. PubMed ID: 392554
    [No Abstract]   [Full Text] [Related]  

  • 59. Towards the clinical use of interferon.
    Cantell K
    Endeavour; 1978; 2(1):27-30. PubMed ID: 95532
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferons.
    Parmar S; Platanias LC
    Cancer Treat Res; 2005; 126():45-68. PubMed ID: 16209062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.